KY9: (2R)-2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-[5-[2-[4-[[4-(hydroxymethyl)piperidin-1-yl]methyl]phenyl]ethynyl]-3-oxidanylidene-7-(trifluoromethyl)-1H-isoindol-2-yl]-N-(1,3-thiazol-2-yl)ethanamide
KY9 is a Ligand Of Interest in 8A2B designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 8A2B_KY9_A_1101 | 90% | 16% | 0.083 | 0.974 | 1.24 | 2.34 | 6 | 18 | 2 | 0 | 100% | 1 |
| 8A27_KY9_A_1102 | 99% | 23% | 0.054 | 0.992 | 1.26 | 1.81 | 7 | 18 | 2 | 0 | 100% | 1 |
| 8A2A_KY9_A_1101 | 86% | 17% | 0.095 | 0.97 | 1.17 | 2.28 | 3 | 15 | 2 | 0 | 100% | 1 |
